Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia-Reference-Cited by-同舟云学术

Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia

Published:2013-09-26 Issue:13 Volume:122 Page:2262-2270
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

La Nasa Giorgio¹²,Caocci Giovanni¹²,Efficace Fabio³,Dessì Carlo⁴,Vacca Adriana¹,Piras Eugenia¹,Sanna Marco¹,Marcias Michela⁴,Littera Roberto⁵,Carcassi Carlo⁵⁶,Lucarelli Guido⁷

Affiliation:

1. Bone Marrow Transplant Center, R. Binaghi Hospital, Cagliari, Italy;

2. Hematology Unit, Department of Medical Sciences “Mario Aresu,” University of Cagliari, Italy;

3. Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases Data Center, Rome, Italy;

4. Department of Clinic and Biology of Developmental Age, Second Institute of Pediatrics, Regional Hospital for Microcytemia, Cagliari, Italy;

5. Regional Transplant Center, R. Binaghi Hospital, Cagliari, Italy;

6. Medical Genetics, Department of Medical Sciences “Mario Aresu,” University of Cagliari, Italy; and

7. Istituto Mediterraneo di Ematologia Foundation, Mediterranean Institute of Hematology, University of Tor Vergata, Rome, Italy

Abstract

Key Points HRQoL and lifestyles of patients transplanted more than 20 years ago for thalassemia are similar to those of the general population. Data on HRQoL in the long term provide both physicians and patients with a more complete picture of the advantages and potential risks of HSCT.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/122/13/2262/1368249/2262.pdf

Reference44 articles.

1. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.;Borgna-Pignatti;Haematologica,2004

2. Surviving with thalassemia major: the Italian experience.;Borgna-Pignatti;Pediatr Hematol Oncol,2007

3. β-thalassemia.;Rund;N Engl J Med,2005

4. Marrow transplantation for thalassaemia.;Thomas;Lancet,1982

5. Allogeneic marrow transplantation for thalassemia.;Lucarelli;Exp Hematol,1984

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Health‐related quality of life with standard and curative therapies in thalassemia: A narrative literature review;Annals of the New York Academy of Sciences;2024-01-25

2. Cognitive and psychosocial functioning in long-term survivors of pediatric hematopoietic stem cell transplant;The Egyptian Journal of Haematology;2024-01

3. Hemoglobinopathies (Sickle Cell Disease and Thalassemia);The EBMT Handbook;2024

4. Magnetic resonance imaging assessment of the changes of cardiac and hepatic iron load in thalassemia patients before and after hematopoietic stem cell transplantation;Scientific Reports;2023-11-10